Skip to content

Neogen NEOG Operating Cash Flow

Operating Cash Flow at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$1.19B+64.9%
Idexx Laboratories logo
Idexx LaboratoriesIDXX
$266.25M+11.9%
Zoetis logo
ZoetisZTS
$401M-22.1%
Revvity logo
RevvityRVTY
$115.23M-10.1%
TEC
Bio-TechneTECH
$86.66M+111%
Agilent Technologies logo
Agilent TechnologiesA
$277M+25.3%

Other financials

Income statement

See full
Revenue$211.2M-4.4%
Gross profit$99.0M-10.2%
Operating income-$3.3M-161%
Net income-$17.0M-56.0%
EPS (diluted)-$0.08-60.0%

Balance sheet

See full
Cash & equivalents$159.9M+25.2%
Total debt$793.3M-11.2%
Total equity$2.1B-21.0%
Total assets$3.4B-16.8%

Cash flow

See full
CapEx$11.6M-64.7%
Free cash flow$11.1M+182%

Valuation

See full
Market cap$1.92B+12.0%
Enterprise value$2.56B+4.4%
P/S2.2×+0.3×

Profitability

See full
Gross margin45.2%-3.6pp
Operating margin-73.1%+77.7pp
Net margin-69.9%+30.8pp
FCF margin-14%

Returns & leverage

See full
Return on equity-25.6%+28.8pp
Debt / equity0.4×0.0×
Current ratio3.9×0.0×

Where this comes from

Reported directly by Neogen in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Neogen’s 10-Q, filed April 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neogen's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neogen's operating cash flow?
Neogen (NEOG) reported operating cash flow of $22.7M in Q4 2025.
How has Neogen's operating cash flow changed year-over-year?
Neogen's operating cash flow increased by 16.7% year-over-year, from $19.46M to $22.7M.
What is the long-term trend for Neogen's operating cash flow?
Over 3 years (2021 to 2025), Neogen's operating cash flow has grown at a -10.4% compound annual growth rate (CAGR), from $81.09M to $58.24M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.